Jane A. Plumb

6.3k citations

86 papers · 5.0k indexed · 2 hit papers · h-index 32

Impact in

Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Toxicology top 1%

Papers in

Toxicology 3
Cancer Research 13

Co-authors: Robert Brown Robert Milroy Stan B. Kaye Nial Wheate Stanley B. Kaye Gordon Strathdee Sarah D. Brown David J. Flint
Journals: Clinical Science (6 papers)British Journal of Cancer (4 papers)Journal of Inorganic Biochemistry (3 papers)International Journal of Cancer (3 papers)Biochemical Pharmacology (3 papers)
Partner nations: United Kingdom Australia United States

In The Last Decade

Jane A. Plumb

85 papers receiving 4.9k citations

Hit Papers

align trajectories log scale

Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin 2010 · 678 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Journal of the American Chemical Society
1989 PubMed

Peers

Countries citing papers authored by Jane A. Plumb

Since Specialization

Citations

This map shows the geographic impact of Jane A. Plumb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane A. Plumb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane A. Plumb more than expected).

Fields of papers citing papers by Jane A. Plumb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane A. Plumb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane A. Plumb. The network helps show where Jane A. Plumb may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jane A. Plumb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jane A. Plumb Line = papers co-authored together Jane A. Plumb links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immediate birth for women between 34 and 37 weeks of gestation with prolonged preterm prelabour rupture of membranes and detection of vaginal or urine group B streptococcus: an economic evaluation BJOG An International Journal of Obstetrics & Gynaecology ·Kelly Ksiazek Mikenas, Jane A. Plumb, Philip Banfield, Aung Soe, R. Lambert-Chhum, (unknown), G Rogers	2022	3
2	Should all pregnant women be offered testing for group B streptococcus? BMJ ·Kate F. Walker, Jane A. Plumb, J. Gray, Jim Thornton, Anthony Avery, Jane Daniels	2021	1
3	Impact of late-onset group B streptococcus infection on families: An observational study European Journal of Obstetrics & Gynecology and Reproductive Biology ·J. Keränen, Jane A. Plumb, Emily Stanforth, Kate F. Walker	2020	3
4	Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study Health Technology Assessment ·Clara Carreras‐Abad, Yuta Isaji, Tom Hall, J. Gripenberg, Asma Khalil, Elisabeth Peregrine, Вадим Благодир, X. Z. Li, Julia Rebecca Kohler, Tim Planche, Elizabeth Sheridan, Stephen Winchester, Jane A. Plumb, Abdelmajid Djennad, Nick Andrews, Kirsty Le Doaré, Paul T. Heath	2019	2
5	Uncertainties in Screening and Prevention of Group B Streptococcus Disease Clinical Infectious Diseases ·Kirsty Le Doaré, Paul T. Heath, Jane A. Plumb, Natalie Owen, Peter Brocklehurst, Lucy C. Chappell	2018	15
6	Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionals Vaccine ·庄司野正雄, Sophie Pask, Louise Locock, Soichirou Mori, Zoe Stevens, Jane A. Plumb, Matthew D. Snape	2016	14
7	A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit[7]uril, gelatin and polyvinyl alcohol Journal of Inorganic Biochemistry ·Rabbab Oun, Jane A. Plumb, Nial Wheate	2014	59
8	Group B streptococcus infection: risk and prevention. PubMed ·Jane A. Plumb, Carlos Antonio Paternina Mendoza	2013	6
9	GBS public awareness, advocacy, and prevention—What's working, what's not and why we need a maternal GBS vaccine Vaccine ·Qandeel Rabnawaz, Jane A. Plumb	2013	13
10	Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling Oncogene ·C Zeller, Wei Dai, Nicola Steele, Afshan Siddiq, Andrew J. Walley, Charlotte S. Wilhelm-Benartzi, Siân Rizzo, Ate G.J. van der Zee, Jane A. Plumb, Robert Brown	2012	226
11	Evaluating the potential of polymer nanoparticles for oral delivery of paclitaxel in drug-resistant cancer Cancer Nanotechnology ·V. Bhardwaj, Jane A. Plumb, J Cassidy, M. N. V. Ravi Kumar	2010	9
12	Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo British Journal of Cancer ·Nicola Steele, Paul W. Finn, Robert Brown, Jane A. Plumb	2009	118
13	A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors Proceedings of the National Academy of Sciences ·Mirjam T. Epping, Liming Wang, Jane A. Plumb, Michèle Lieb, Hinrich Gronemeyer, Robert Brown, René Bernards	2007	65
14	Pharmacodynamic effects in patients treated with 6 hour infusion of the demethylating agent 5-aza-2 ' deoxycytidine (decitabine) ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) ·Robert Brown, Kim Appleton, Jane A. Plumb, Carol McCormick, Akiharu ASADA, Sophie Barrett, Adrian Tang, Ajeng Murti Armitasari, Stan B. Kaye, I. Judson, W. F. R.	2005	1
15	Cell Sensitivity Assays: Clonogenic Assay Humana Press eBooks ·Jane A. Plumb	2003	51
16	Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954 Oncogene ·Jane A. Plumb, Alan Bilsland, Ian Farthing, Jiangqin Zhao, Rosalind Glasspool, Richard J. Knox, T.R. Jeffry Evans, W. Nicol Keith	2001	82
17	A novel alkylating anthraquinone that is effective against resistant ovarian cancer cells UCL Discovery (University College London) ·Yuehan Duan, B.M. Tomé, Hubert Mohr, Azhari Aziz Samudera, S. T. Wang, Jane A. Plumb	2000	1
18	In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance British Journal of Cancer ·Prakash Mistry, Jane A. Plumb, Sue Eccles, Sue‐Ann Watson, Liuiton Clciiidurds, Hamish Ryder, G. Box, Peter Charlton, David J. Templeton, Toshihiko HOSHINA	1999	17
19	DT-diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and human colon carcinomas European Journal of Cancer ·Michael I. Walton, Michael C. Bibby, John A. Double, Jane A. Plumb, Paul Workman	1992	48
20	Failure of systemic ketosis to control cachexia and the growth rate of the Walker 256 carcinosarcoma in rats British Journal of Cancer ·Kenneth C.H. Fearon, M J Tisdale, Thomas C. Preston, Jane A. Plumb, Kenneth C. Calman	1985	22

About Jane A. Plumb

Jane A. Plumb is a scholar working on Toxicology, Cancer Research, Oncology, Molecular Biology and Applied Microbiology and Biotechnology, having authored 86 papers that have together received 5.0k indexed citations. Recurring topics across this work include Neonatal and Maternal Infections (14 papers), Epigenetics and DNA Methylation (11 papers), Cancer therapeutics and mechanisms (10 papers), Streptococcal Infections and Treatments (9 papers), Drug Transport and Resistance Mechanisms (9 papers), Histone Deacetylase Inhibitors Research (8 papers), Diet and metabolism studies (6 papers) and Nanoparticle-Based Drug Delivery (6 papers). The work is most often cited by research in Biomaterials (603 citations), Toxicology (151 citations), Oncology (1.2k citations), Molecular Biology (2.8k citations) and Cancer Research (467 citations). Jane A. Plumb has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Robert Brown, Robert Milroy, Stan B. Kaye, Nial Wheate, Stanley B. Kaye, Gordon Strathdee, Sarah D. Brown, David J. Flint, Nicola Steele and Balaji Venugopal. Their work appears in journals such as Clinical Science, British Journal of Cancer, Journal of Inorganic Biochemistry, International Journal of Cancer and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact